• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Fukuda Takeshi  福田 武史

ORCIDConnect your ORCID iD *help
Researcher Number 70570638
Other IDs
Affiliation (Current) 2025: 大阪公立大学, 大学院医学研究科, 准教授
Affiliation (based on the past Project Information) *help 2024 – 2025: 大阪公立大学, 大学院医学研究科, 准教授
2022 – 2023: 大阪公立大学, 大学院医学研究科, 講師
2021: 大阪市立大学, 大学院医学研究科, 講師
Review Section/Research Field
Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related
Except Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related
Keywords
Principal Investigator
MPE解析 / 細菌 / 卵巣がん
Except Principal Investigator
バイオマーカー / 化学療法 / TBX2 / CLPTM1L / 治療効果予測 / パクリタキセル / シスプラチン / 術後補助療法 / 子宮頸癌
  • Research Projects

    (2 results)
  • Research Products

    (18 results)
  • Co-Researchers

    (8 People)
  •  卵巣がんに特異的な細菌に着目したMPE解析による病態解明と新規治療法の開発Principal Investigator

    • Principal Investigator
      福田 武史
    • Project Period (FY)
      2025 – 2029
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Metropolitan University
  •  Efficacy and predictive factors of TP therapy as adjuvant treatment in intermediate‑ and high‑risk stage IB‑IIB cervical cancer

    • Principal Investigator
      Sumi Toshiyuki
    • Project Period (FY)
      2019 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Metropolitan University
      Osaka City University

All 2024 2023 2022 2020

All Journal Article Presentation

  • [Journal Article] Predicting recurrence in intermediate? and high?risk stage IB?IIB cervical cancer treated with adjuvant cisplatin and paclitaxel chemotherapy post?radical hysterectomy: The role of TBX2 expression2024

    • Author(s)
      Noda Takuya、Fukuda Takeshi、Uchikura Eijiro、Awazu Yuichiro、Wada Takuma、Tasaka Reiko、Yamauchi Makoto、Yasui Tomoyo、Sumi Toshiyuki
    • Journal Title

      Oncology Letters

      Volume: 28 Issue: 3

    • DOI

      10.3892/ol.2024.14547

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Journal Article] CLPTM1L expression predicts recurrence of patients with intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy2023

    • Author(s)
      Yuichiro Awazu, Takeshi Fukuda, Takuya Noda, Eijiro Uchikura, Shigenori Nanno, Kenji Imai, Makoto Yamauchi, Tomoyo Yasui, Toshiyuki Sumi
    • Journal Title

      Oncol Lett

      Volume: 26 Issue: 2

    • DOI

      10.3892/ol.2023.13939

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] TBX2 expression predicts recurrence of intermediate and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy2024

    • Author(s)
      野田拓也、福田武史、内倉慧二郎、 粟津祐一郎、田坂玲子、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第76回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] TBX2の発現は広汎子宮全摘出後に補助療法としてTP療法を行った子宮頸癌の再発予測因子となる2024

    • Author(s)
      野田拓也、福田武史、内倉慧二郎、 粟津祐一郎、田坂玲子、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第66回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] Predicting recurrence in intermediate- and high-risk stages IB-IIB cervical cancer treated adjuvant chemotherapy post-radical hysterectomy: the role of TBX2 expression2024

    • Author(s)
      Noda T, Fukuda T, Uchikura E, Wada T, Tasaka R, Yamauchi M, Yasui T, Sumi T
    • Organizer
      International Gynecologic Cancer Society Annual Global Meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1L expression predicts recurrence of intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy.2023

    • Author(s)
      粟津祐一朗、福田武史、内倉慧二郎、野田拓也、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第75回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] TBX2 expression is associated with recurrence of intermediate- and high- risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy2023

    • Author(s)
      野田拓也、福田武史、内倉慧二郎、 粟津祐一郎、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第75回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1L expression predicts recurrence of intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy2023

    • Author(s)
      粟津祐一郎、福田武史、野田拓也、内倉慧二郎、 南野成則、今井健至、和田卓磨、山内 真、安井智代、角 俊幸
    • Organizer
      International Gynecologic Cancer Society
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1L expression predicts recurrence of intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy2023

    • Author(s)
      粟津祐一郎、福田武史、野田拓也、内倉慧二郎、 南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第75回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] TBX2 の発現は術後補助療法として TP 療法を行った再発リスクを有する子宮頸癌の再発と関連する2023

    • Author(s)
      野田拓也、福田武史、内倉慧二郎、 粟津祐一郎、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第65回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1L の発現は広汎子宮全摘出後に補助療法として TP 療法を行なった子宮頸癌 の再発予測因子となる2023

    • Author(s)
      粟津祐一郎、福田武史、野田拓也、内倉慧二郎、 南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第65回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1Lの発現は広汎子宮全摘出後に補助療法としてTP療法を行なった子宮頸癌の再発予測因子となる2023

    • Author(s)
      粟津祐一朗、福田武史、内倉慧二郎、野田拓也、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第65回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1Lの発現は術後補助療法としてTP療法を行った再発リスクを有する子宮頸癌の再発と関連する2022

    • Author(s)
      粟津祐一朗、福田武史、内倉慧二郎、野田拓也、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第64回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1L expression predicts recurrence of intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherap2022

    • Author(s)
      粟津祐一朗、福田武史、内倉慧二郎、野田拓也、南野成則、今井健至、山内 真、安井智代、角 俊
    • Organizer
      第74回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1L expression predicts recurrence of intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy2022

    • Author(s)
      粟津祐一朗、福田武史、内倉慧二郎、野田拓也、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第74回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] CLPTM1Lの発現は術後補助療法としてTP療法を行った再発リスクを有する子宮頸癌の再発と関連する2022

    • Author(s)
      粟津祐一朗、福田武史、内倉慧二郎、野田拓也、南野成則、今井健至、山内 真、安井智代、角 俊幸
    • Organizer
      第64回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] Paclitaxel plus cisplatin as adjuvant chemotherapy after radical hysterectomy for intermediate and high risk stage IB-IIB cervical cancer2020

    • Author(s)
      南野成則、山内真、下村将央、井上裕太、松原裕明、笠井真理、福田武史、橋口裕紀、市村友季、安井智代、角俊幸
    • Organizer
      第72回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • [Presentation] Paclitaxel plus cisplatin as adjuvantchemotherapy after radical hysterectomy for intermediate and high risk stage IB-IIB cervical cancer2020

    • Author(s)
      南野成則、山内真、下村将央、井上裕太、松原裕明、笠井真理、福田武史、橋口裕紀、市村友季、安井智代、角俊幸
    • Organizer
      第72回日本産婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09808
  • 1.  Sumi Toshiyuki (50315991)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 18 results
  • 2.  市村 友季 (50364005)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 3.  安井 智代 (20347488)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 18 results
  • 4.  笠井 真理 (30735585)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 5.  山内 真 (10837850)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 18 results
  • 6.  今井 健至 (20913221)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 13 results
  • 7.  和田 卓磨 (21008394)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 8.  康 秀男 (90419698)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi